Annual Cash & Cash Equivalents
$103.84 M
+$1.36 M+1.33%
December 31, 2023
Summary
- As of February 8, 2025, ORGO annual cash & cash equivalents is $103.84 million, with the most recent change of +$1.36 million (+1.33%) on December 31, 2023.
- During the last 3 years, ORGO annual cash & cash equivalents has risen by +$19.45 million (+23.04%).
- ORGO annual cash & cash equivalents is now -8.86% below its all-time high of $113.93 million, reached on December 31, 2021.
Performance
ORGO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$94.34 M
+$4.44 M+4.94%
September 30, 2024
Summary
- As of February 8, 2025, ORGO quarterly cash and cash equivalents is $94.34 million, with the most recent change of +$4.44 million (+4.94%) on September 30, 2024.
- Over the past year, ORGO quarterly cash and cash equivalents has dropped by -$9.50 million (-9.15%).
- ORGO quarterly cash and cash equivalents is now -17.19% below its all-time high of $113.93 million, reached on December 31, 2021.
Performance
ORGO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ORGO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | -9.2% |
| 3 y3 years | +23.0% | -9.2% |
| 5 y5 years | +387.7% | +310.6% |
ORGO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +1.3% | -17.2% | +6.5% |
| 5 y | 5-year | -8.9% | +72.6% | -17.2% | +158.4% |
| alltime | all time | -8.9% | >+9999.0% | -17.2% | >+9999.0% |
Organogenesis Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $94.34 M(+4.9%) |
| Jun 2024 | - | $89.90 M(+1.4%) |
| Mar 2024 | - | $88.63 M(-14.7%) |
| Dec 2023 | $103.84 M(+1.3%) | $103.84 M(+5.7%) |
| Sep 2023 | - | $98.23 M(+10.5%) |
| Jun 2023 | - | $88.92 M(+0.3%) |
| Mar 2023 | - | $88.69 M(-13.5%) |
| Dec 2022 | $102.48 M(-10.1%) | $102.48 M(-4.4%) |
| Sep 2022 | - | $107.25 M(-4.5%) |
| Jun 2022 | - | $112.28 M(+4.1%) |
| Mar 2022 | - | $107.90 M(-5.3%) |
| Dec 2021 | $113.93 M(+35.0%) | $113.93 M(+11.4%) |
| Sep 2021 | - | $102.24 M(+13.9%) |
| Jun 2021 | - | $89.79 M(+15.9%) |
| Mar 2021 | - | $77.46 M(-8.2%) |
| Dec 2020 | $84.39 M | $84.39 M(+131.1%) |
| Sep 2020 | - | $36.51 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $40.45 M(-13.7%) |
| Mar 2020 | - | $46.90 M(-22.1%) |
| Dec 2019 | $60.17 M(+182.6%) | $60.17 M(+161.9%) |
| Sep 2019 | - | $22.97 M(+14.6%) |
| Jun 2019 | - | $20.04 M(-34.4%) |
| Mar 2019 | - | $30.56 M(+43.5%) |
| Dec 2018 | $21.29 M(+822.1%) | $21.29 M(>+9900.0%) |
| Sep 2018 | - | $2700.00(-95.8%) |
| Jun 2018 | - | $64.40 K(-35.3%) |
| Mar 2018 | - | $99.50 K(-95.7%) |
| Dec 2017 | $2.31 M(+122.0%) | $2.31 M(+1861.8%) |
| Sep 2017 | - | $117.70 K(-58.9%) |
| Jun 2017 | - | $286.50 K(-41.1%) |
| Mar 2017 | - | $486.20 K(-53.3%) |
| Dec 2016 | $1.04 M(+724.8%) | $1.04 M(+505.4%) |
| Sep 2016 | - | $171.80 K(+61.9%) |
| Jun 2016 | - | $106.10 K |
| Dec 2015 | $126.10 K | - |
FAQ
- What is Organogenesis Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Organogenesis Holdings?
- What is Organogenesis Holdings annual cash & cash equivalents year-on-year change?
- What is Organogenesis Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly cash and cash equivalents year-on-year change?
What is Organogenesis Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ORGO is $103.84 M
What is the all time high annual cash & cash equivalents for Organogenesis Holdings?
Organogenesis Holdings all-time high annual cash & cash equivalents is $113.93 M
What is Organogenesis Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ORGO annual cash & cash equivalents has changed by +$1.36 M (+1.33%)
What is Organogenesis Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ORGO is $94.34 M
What is the all time high quarterly cash and cash equivalents for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly cash and cash equivalents is $113.93 M
What is Organogenesis Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ORGO quarterly cash and cash equivalents has changed by -$9.50 M (-9.15%)